CND LIFE SCIENCES
CND Life Sciences develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy. CND launched the Syn-One Test, a commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid in the confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF). CND has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field.
CND LIFE SCIENCES
Industry:
Biotechnology Health Diagnostics Life Science
Founded:
2017-01-01
Address:
Phoenix, Arizona, United States
Country:
United States
Website Url:
http://www.cndlifesciences.com
Total Employee:
1+
Status:
Active
Contact:
480-569-2900
Total Funding:
9.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institute on Aging
National Institute on Aging investment in Grant - CND Life Sciences
Peter Harris
Peter Harris investment in Seed Round - CND Life Sciences
HonorHealth
HonorHealth investment in Seed Round - CND Life Sciences
Cambrian Capital Partners
Cambrian Capital Partners investment in Seed Round - CND Life Sciences
HonorHealth
HonorHealth investment in Seed Round - CND Life Sciences
Peter Harris
Peter Harris investment in Seed Round - CND Life Sciences
Official Site Inspections
http://www.cndlifesciences.com Semrush global rank: 4.49 M Semrush visits lastest month: 2.41 K
- Host name: 28.188.83.34.bc.googleusercontent.com
- IP address: 34.83.188.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
